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The immune response by inbred strains of mice to the random terpolymer 
L-glutamic acid6°-L-alaninea°-L-tyrosine 1°  (GAT)  1 is  controlled by an  immune 
response  (Ir)  gene(s)  which maps within the 1t-2 complex between the genes 
controlling expression of the major histocompatibility antigens, 11-2 (1-3). In 
the  preceding paper  (4),  we  demonstrated  that  IgG  GAT-specific  plaque- 
forming cell  (PFC)  responses  developed  in  cultures  of spleen  cells  from  re- 
sponder mice, C57B1/6 (H-2~), F1(C57  >(SJL) (11-2b/*), and A/J (H-2a), incu- 
bated for 5 days with 1-10 #g soluble GAT. No PFC specific for GAT developed 
in cultures of spleen cells from nonresponder mice, SJL (11-20,  B10.S  (11-20, 
and  A.SW  (11-20,  after incubation with  soluble  GAT.  However,  cultures  of 
spleen cells  from both responder and nonresponder strains of mice developed 
IgG GAT-specific PFC  responses  after  incubation  with  GAT  complexed  to 
methylated  bovine  serum  albumin,  an  immunogenic  carrier  in  11-28 mice, 
(GAT-MBSA). 
Since these data correlated precisely with data obtained by measuring the 
in vivo responses of mice to GAT and GAT-MBSA by serological techniques 
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09929 from the National Institute of Allergy  and Infections  Diseases. 
Recipient of U.S. Public Health Service Research Career Development Award 1K4-AI- 
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1  Abbreviations used in this paper: B cell, bone marrow-derived cell, precursor of antibody- 
producing cell; C, complement; GAT, random terpolymer of L-glutamic  acid6°-L-alanine~°-L  - 
tyrosinel°; GAT-MBSA,  GAT complexed to methylated bovine serum albumin; GAT-SRBC, 
GAT coupled to sheep red blood cells; H-2, major histocompatibility locus in mice; HBSS, 
Hanks' balanced salt solution lacking sodium bicarbonate; Ig, immunoglobulin, IgG is used to 
refer to both IgGl and IgG~a+2b  Ig; Ir gene, immune  response gene;  M~, macrophages;  MEM, 
completely supplemented Eagle's minimum essential medium; NA cells, cells nonadherent to 
culture dishes, mostly lymphoid cells; PFC, plaque-forming cell(s); SRBC, sheep red  blood 
cells; T cell, thymus-derived  cell, helper cell; theta, surface alloantigen on T cells. 
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(1, 2, 5,  6), we feel this in vitro system can effectively be used as a  model to 
investigate the mechanism(s) by which histocompatibility-linked  Ir genes regu- 
late the antibody response. Data obtained with both in vivo (5, 6) and in vitro 
(4)  experimental  systems  have  demonstrated  that  nonresponder mice,  like 
responder mice, have precursors of antibody-producing  cells (B cells) capable of 
synthesizing GAT-specific antibodies if the appropriate thymus-derived cell (T 
cell) helper function is provided. These observations indicate that the genetic 
defect or the cell in which the Ir gene function is necessarily expressed is not 
the B  cell. In addition to B  cells, two accessory cells, the nonspecific macro- 
phage, and the antigen-specific T  cell, are also required for the development of 
primary PFC responses in vitro to most complex, multi-determinant  antigens, 
such as  sheep  red  blood cells  (SRBC)  (7)  or hapten conjugates  (8).  In  this 
communication,  we describe experiments investigating  the cellular requirements 
for the development of GAT-specific PFC responses to GAT and GAT-MBSA 
by spleen cells from responder and nonresponder mice in vitro. 
Materials and Methods 
Mice.--C57Bl/6J  (H-2~), SJL/J (H-28), AKR/J (H-2k), and C~H/HeJ  (H-2 k)  mice were 
purchased from Jackson Laboratories, Bar Harbor, Me., B10.S (1t-20 mice were a gift from 
Dr. D. Shreffier, University of Michigan and have been bred in our animal facilities. Mice used 
in these experiments were from 2 to 8-too old and were maintained on acidified-chlorinated 
water and laboratory chow ad lib. 
Antigens.--Two preparations of GAT were used in these studies: the first, molecular weight 
55,000, was purchased from Pilot Chemicals, Division of New England Nuclear Corp., Boston, 
Mass.;  the second, molecular weight  32,000, was  purchased  from Miles Laboratory,  Kan- 
kakee, II1. Preparations  of the solutions of GAT, GAT complexed to MBSA, and SRBC for 
addition to spleen cell cultures were described in detail in the preceding paper (4). 
Preparation of GAT-SRBC.--GAT  was coupled to SRBC for use as indicator cells in the 
hemolytic plaque assay as described in the preceding paper (4). 
Anti-Theta  Serum.--Anti-theta  serum  was  prepared  in AKR/J  mice by  multiple in- 
jections of C3H/HeJ thymus cells according to the  method of Raft  (9) with  modifications 
described previously  (10). The serum used in these experiments had no cytotoxic activity 
against AKR/J thymus cells when tested by 51Cr release assay (10). This serum was cytotoxic 
for 85-90% of thymus cells from C57B1/6, B10.S, and SJL mice at final dilutions up to 1/120 
in the presence of guinea pig serum  (BBL, Division of BioQuest, Cockeysville, Md.)  as a 
source of complement (C). At these same dilutions, this serum was cytotoxic for 20-27% of 
spleen cells from these strains of mice. 
Immunization  of Mice.--Mice were immunized with 10 ~g GAT or 10 #g GAT as GAT- 
MBSA as a suspension in a mixture of magnesium-alumlnum hydroxide gels (Maalox, Wm. 
H. Rorer, Inc., Fort Washington, Pa.) and pertussls vaccine (Eli Lilly Co., Indianapolis, Ind.) 
as previously described (1). 
Spleen Cell Cultures.--Spleen  cells or fractionated spleen cell populations as suspensions of 
dispersed single cells were incubated at a density of 10 or 20 X  106 cells/ml in completely 
supplemented Eagle's minimum  essential medium (MEM) according to the method of 1Y[ishell 
and Dutton (11) with modification previously described in detail  (12). Experimental groups 
were duplicate cultures and each experiment contained cultures which were unstimulated  or 
stimulated with  10 7 SRBC, 10 #g GAT, or 2.5-5.0 #g GAT as GAT-MBSA. PFC responses 
were assayed after 5 days incubation. J.  A.  KAPP~ C.  W.  PIERCE~  AND  B.  BENACERRAF  1123 
Cdl  Separation  Techniques.--Suspensions  of  spleen  cells  were  separated  into  adherent 
(mostly macrophages) and nonadherent (mostly lymphoid cells) populations by passage over 
plastic petri dishes according to the technique of Mosier  (13) with modifications previously 
described (7). Briefly, 10 X  106 spleen cells in 1 ml of MEM were incubated for 1-11/4 h  in 
35 mm culture dishes at 37°C on a level stationary platform. The nonadherent cells were then 
gently resuspended and transferred to new culture dishes. After two additional incubation 
periods and transfers, nonadherent cells were collected by centrifugation and resuspended in 
MEM at 10 X  106 cells/ml. Cells adhering to the culture dishes during the first incubation 
period were washed extensively with Hanks' balanced salt solution (HBSS) to remove loosely 
adhering cells.  The adherent and nonadherent cells were incubated with antigen either sepa- 
rately or after recombination. 
Theta-bearing cells (T cells) were eliminated from spleen cell suspensions by treatment with 
AKR  anti-theta and  C. 0.3 ml  of  anti-theta serum per  100  X  106 cells was  reacted with 
spleen cells at 4°C for 30 min. The spleen cells were then diluted with 50 ml of HBSS,  col- 
lected by centrifugation and resuspended in guinea pig serum, as a source of C. The guinea pig 
serum, previously absorbed with normal C57B1/6 spleen cells  to  remove nonspecific cyto- 
toxicity, was diluted 1:3 in Medium L-15  (Microbiological Associated, Bethesda, Md.) con- 
taining 10/~g/ml deoxyribonuclease (Worthington Biochemical Corp.,  Freehold, N.  J.)  and 
4  ml added per 100  X  106 spleen cells.  Mter incubation at 37°C for 45 rain, the cells were 
washed twice by centrifugation with 50 ml of HBSS and resuspended in MEM at 20 X  106 
cells/ml MEM. 10 X  106 cells in 0.5 ml MEM were added to cultures with or without addi- 
tional cells and antigen according to the experimental protocol. 
Source of T  Cdls.--Antigen-primed mouse T  cells are radioresistant in vivo whereas un- 
primed T cells and B cells are radiosensitive (14). Mice primed with 10 #g GAT or 10 #g GAT 
as GAT-MBSA in Maalox-pertussis 1--4 mo earlier were X-irradiated with 700 to 800 R  de- 
livered by a  General Electric Maximar 250 Type III X-ray therapy unit  (General Electric 
Co., Schenectady, N. Y.)  (250 kVP,  15 mA) at 36 R/min through 0.5 mm Cu,  1.0  mm  A1 
filters. Within 3 h  of X-irradiation, single cell suspensions were prepared from the spleens of 
these mice and adjusted to 20 X  106 cells/ml in MEM.  10 X  106 cells in 0.5 ml MEM were 
added to cultures with or without additional cells and antigen according to the experimental 
protocol. 
Peritoneal Exudate Cdls.--Mice were injected intraperitoneally with 1.0 ml of sterile 10~o 
proteose peptone broth (Difco Laboratories, Detroit, Mich.) 3 days before sacrifice. Mice were 
sacrificed by cervical dislocation and 3 ml HBSS containing 10 U/ml heparin was introduced 
aseptically into the peritoneal cavity. The cells were recovered by gentle aspiration of the 
HBSS and were washed four times by centrifugafion. This procedure routinely yielded about 
8-15  X  106 cells/mouse, approximately 85% of which were morphologically typical macro- 
phages (15). 
Preparation  of Macrophage Bound  GAT.--The  preparation  of  GAT-macrophages  was 
modified from the procedure of Katz and Unanue (15). Peritoneal exudate macrophages (2 m] 
containing 2 X  106 cells/ml MEM)  from C57B1/6 or SJL mice were reacted with 2.0, 20.0, or 
200.0/zg GAT containing a small, known amount of GAT labeled with 125I by a  chloramine 
T  method (16),  (total volume of 2.2 ml) for 60 min at 4°C. The cells were then washed four 
times by centrifugation with 50 ml of HBSS at 4°C. The cells were resuspended to 7 X  105 
cells/ml in MEM. The radioactivity in an aliquot of each macrophage preparation was counted 
in a  Packard scintillation counter  (Packard Instrument Co., Downers Grove, Ill.)  and the 
amount of GAT bound to the macrophages was calculated. 7  X  104 macrophages in 0.1 ml 
MEM were added to cultures according to the experimental protocol. Under these conditions, 
the uptake of GAT was linearly related to the amount of GAT added to the reaction mixture 
Macrophages used in these studies were exposed to 200 ~g GAT and the average uptake by 
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The solution containing 200 #g GAT was not depleted of absorbable GAT after incubation 
with 2 X  108 macrophages. 2 X  l0  s macrophages were incubated with the supernate from the 
first absorption and the process repeated a third time. The quantity of GAT absorbed by each 
of these preparations of macrophages was approximately equal. 
Hemolytic Plaque Assay.--IgM and IgG PFC in spleen cell cultures were enumerated by a 
modification of the Jerne hemolytic plaque technique described previously  (12).  Spleen cell 
suspensions, after harvest from culture, were washed three times by centrifugation to remove 
any soluble GAT. Each spleen cell suspension was examined for IgM and IgG PFC against 
SRBC and GAT-SRBC indicator cells.  The specificity of PFC on GAT-SRBC for GAT was 
verified by adding  10/~g of soluble GAT to  the assay mixtures to inhibit anti-GAT PFC. 
GAT-specific PFC were calculated by subtracting the number of PFC uninhibited by soluble 
GAT on GAT-SRBC  from  the number of  PFC detected on GAT-SRBC in the absence of 
soluble GAT. Data are expressed as GAT-specific PFC/culture. 
RESULTS 
Macrophage Requirement  for Development of Primary PFC Responses to GA T 
In Vitro.--Spleen  cells from responder, C57B1/6, mice and nonresponder, SJL, 
mice were separated into adherent (macrophages)  and nonadherent (lymphoid 
cells) populations.  Cultures of unfractionated spleen cells, macrophages,  non- 
adherent  cells,  and  these  latter  two  populations  after  recombination  were 
stimulated with l0  T  SRBC, 10/~g GAT, or 5 #g GAT as GAT-MBSA (Fig.  1). 
Although not shown here,  but demonstrated in other reports (7,  12), the de- 
velopment of anti-SRBC PFC responses  in cultures of nonadherent cells from 
both C57B1/6 and SJL mice required macrophages. As shown, the development 
of primary IgG GAT-specific  PFC responses by cultures of nonadherent  cells 
from C57B1/6 mice stimulated with GAT and GAT-MBSA and by cultures of 
nonadherent cells from SJL mice stimulated with GAT-MBSA required macro- 
phages. 
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FIo.  1.  Ma~rophage requirement for the development of  GAT-specific PFC responses in 
cultures of spleen cells from C57B1/6  mice  stimulated with  10  /zg/culture GAT or 5.0/zg/ 
culture  of  GAT  as  GAT-MBSA and  in cultures  of  spleen cells from SJL mice stimulated 
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Ability of Allogeneic  Macrophages  to Support Development of Primary PFC 
Responses  to GA T  In  Vitro.--Cosenza  and Leserman have previously shown 
that macrophages will support the development of PFC  responses by histo- 
incompatible nonadherent cells stimulated in vitro with SRBC (17). In the next 
experiment (Fig. 2), we compared the PFC responses developed by nonadherent 
cells incubated with  allogeneic macrophages  to  those which  developed with 
syngeneic macrophages. Macrophages and nonadherent cells in this experiment 
were from the same preparations of cells used in the experiment described in 
Fig. 1. 
SJL macrophages supported not only development of anti-SRBC  PFC re- 
sponses, but also development of IgG GAT-specific PFC responses by C57B1/6 
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Fio. 2.  Comparison  of the ability of syngeneic  and allogeneic  macrophages to support the 
development of PFC responses by nonadherent spleen cells stimulated with 10  ~' SRBC, 10 
/zg/culture GAT, or 5.0 #g/culture GAT as GAT-MBSA.  The macrophages and nonadherent 
cells used in this experiment  were from the same preparations as those used in the experiment 
described in Fig. 1. 
nonadherent cells incubated with GAT or GAT-MBSA. This demonstrates that 
macrophages from nonresponder mice are not defective with regard to their 
ability to support responses to soluble GAT. C57B1/6 macrophages supported 
development of PFC responses by SJL nonadherent cells to SRBC and GAT- 
MBSA, but not to soluble GAT. Thus, the ability to develop a  GAT-specific 
PFC response after stimulation with soluble GAT is determined by the geno- 
type of the nonadherent cells, not the macrophages. 
Ability of GA T  Bound to Macrophages  to Support Development of Primary 
PFC Responses In Vitro.--The elimination of macrophages from nonadherent 
cell populations by adherence techniques is not absolute. In the preceding ex- 
periment, it is possible to argue that SJL macrophages support the viability 
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taminating  C57B1/6  macrophages which  actually  interact  with  and  present 
GAT in a manner which stimulates development of GAT-specific PFC response 
by the C57B1/6 nonadherent cells. 
We have carried out a series of experiments demonstrating that SJL macro- 
phages are, indeed, able to support the development of IgG GAT-specific PFC 
responses by C57B1/6 nonadherent  cells.  Small amounts of antigen bound  to 
peritoneal exudate macrophages can effectively stimulate development of PFC 
responses in cultures of spleen cells from mice previously immunized with  the 
antigen (15). Peritoneal exudate macrophages from responder and nonresponder 
mice were reacted with GAT as described in Methods and the amount of GAT 
associated with the macrophages was determined. C57B1/6 macrophages bear- 
ing  0.4  ng  GAT and  SJL macrophages bearing  0.9  ng  GAT were  added  to 
cultures of nonadherent cells from unprimed C57B1/6 mice without additional 
soluble GAT. Soluble GAT, 10 #g, 0.4 ng, or 0.9 ng, was added to  cultures of 
C57B1/6 or SJL macrophages and C56B1/6 nonadherent  cells as  indicated  in 
Fig. 3. The subnanogram quantities of GAT associated with either C57B1/6  or 
SJL macrophages stimulated  GAT-specific PFC  responses  by C57BI/6  non- 
adherent  cells which  approximated the  responses in  cultures  to which  10 #g 
soluble GAT was added. When the equivalent subnanogram quantities of GAT 
which were associated with macrophages were added to cultures as soluble GAT, 
no significant PFC response developed. 
T  Cell Requirement for  Development of  GAT-Specific  PFC Responses In 
Vitro.--The T  cell requirement for the development of GAT-specific PFC re- 
sponses in cultures of spleen cells from responder and nonresponder mice was 
determined  by depletion  of theta-bearing  cells  from  the  spleen  cell  suspen- 
sions. Spleen cells were incubated with anti-theta serum and  C before culture 
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FIG. 3.  Comparison of the ability of GAT bound syngeneic  and allogeneic macrophages to 
support the development of GAT-specific  PFC responses by cultures of nonadherent spleen 
cells from responder, C57B1/6, mice in the absence of free soluble GAT. J.  A.  KAPP,  C.  W.  PIERCE,  AND  B.  BENACERRAF  1127 
initiation. In addition, 10 X  106 spleen cells from mice which had been primed 
with GAT or GAT-MBSA in Maalox-pertussis  1-4 mo earlier and X-irradiated 
(720 R) before sacrifice were incubated with antigen either alone or in combina- 
tion with 10 X  106 anti-theta-treated spleen cells. Spleen cells from C57B1/6 
mice  treated with anti-theta serum and  C failed to develop  PFC  responses 
to SRBC, GAT and GAT-MBSA (Fig. 4). Spleen cells from X-irradiated, GAT 
or GAT-MBSA primed C57B1/6 mice also failed to develop GAT-specific PFC 
responses  when incubated  alone  with  GAT-MBSA.  However,  when  these 
spleen  cells were  added  to  cultures  of  anfi-theta-treated  C57B1/6 spleen 
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FIG. 4.  Requirement for thymus-derived helper cells for the development of BAT-specific 
PFC responses by cultures of spleen cells from responder, C57B1/6, mice to 10 #g/culture GAT 
or 5.0 #g/culture BAT as GAT-MBSA. 
cells the GAT-specific PFC responses to GAT and GAT-MBSA were fully re- 
constituted. The same experiment was performed with spleen cells from normal 
and  primed nonresponder  B10.S mice which  differ from C57B1/6 mice only 
at the H-2 complex (Fig. 5). The  results in Fig. 5 demonstrate that the de- 
velopment of GAT-specific PFC responses by spleen cells from nonresponder 
mice  stimulated with  GAT-MBSA  is  also T  cell dependent.  Helper T  cell 
function in the response to GAT-MBSA was restored by spleen cells from X-ir- 
radiated B10.S mice primed with GAT-MBSA  but not by spleen  cells from 
X-irradiated BI0.S mice primed with GAT. 
DISCUSSION 
These experiments  demonstrate that macrophages  are required  for the de- 
velopment of primary GAT-specific PFC responses in vitro by nonadherent 
spleen cells from responder mice stimulated with GAT or GAT-MBSA and by 1128  GENETIC CONTROL OF  IMMUNE RESPONSES IN VITRO 
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nonadherent spleen cells fronl nonresponder mice stimulated with GAT-MBSA. 
Macrophages from responder, C57B1/6, mice and from nonresponder, SJL, mice 
supported equally the development of PFC responses by allogeneic nonadherent 
spleen  cells in  cultures  stimulated  with  SRBC  and  GAT-MBSA.  However, 
macrophages from C57B1/6 mice did not confer the ability to develop GAT- 
specific PFC responses to nonadherent nonresponder spleen cells in  cultures 
stimulated with GAT. Thus, the responder status to GAT is determined by the 
genotype of the nonadherent cells,  not by the genotype of the macrophages. 
Equally important is the observation that nonresponder macrophages are not 
defective in their ability to support development of GAT-specific PFC responses 
by nonadherent responder spleen cells in cultures stimulated with GAT. Not 
only did nonresponder macrophages support development of GAT-specific PFC 
responses by nonadherent responder spleen cells in  cultures stimulated  with 
soluble  GAT but,  like  responder macrophages,  they stimulated  comparable 
responses by nonadherent responder spleen cells when the only GAT in  the 
cultures was provided in subnanogram  amounts bound  to the macrophages. 
Thus, macrophage function with regard to GAT is the same in cultures of spleen 
ceils from responder and nonresponder mice and the macrophage is not respon- 
sible for the failure of nonresponder spleen cells  to develop PFC responses to 
soluble GAT. One additional conclusion can be drawn from these data. That is: 
in the primary PFC response to soluble antigens in vitro, one function of macro- 
phages is definitely antigen presentation. Our results and the earlier experiments 3.  A.  KAPP, C.  W.  PIERCE, AND  B.  BENACERRA]F  1129 
of Katz and Unanue (15) are in apparent contradiction with the recent findings 
of Rosenthal  and  Shevach  2 that  in guinea pigs,  antigen-bearing histoincom- 
patible macrophages are much less efficient in stimulating DNA synthesis by 
sensitized  T  cells  than  syngeneic or  semi-syngeneic macrophages.  This  dis- 
crepancy could be attributed to a species difference in macrophage function or 
to the possibility that specific helper T  cells are not the limiting factor in anti- 
body responses in vitro. According to this concept, a sufficient number of helper 
T  cells could be stimulated by allogeneic macrophages. This issue can be re- 
solved experimentally and does not invalidate our conclusion that the Ir gene 
need not be expressed in macrophages. 
We have also shown that treatment of spleen cells from responder mice with 
anti-theta serum and C before culture initiation abolishes the development of 
PFC responses to SRBC, GAT, and GAT-MBSA. Similar treatment of spleen 
cells from nonresponder mice abolishes the development of PFC responses in 
cultures stimulated with SRBC and GAT-MBSA. Spleen cells from responder 
mice which had been primed with GAT or GAT-MBSA and X-irradiated before 
addition to the cultures reconstituted GAT-specific PFC responses to both GAT 
and  GAT-MBSA  by  anti-theta-treated  spleen  cells  from  responder  mice. 
Similarly, spleen cells from X-irradiated B10.S mice previously primed with 
GAT-MBSA, but not those primed with GAT, reconstituted GAT-specific PFC 
responses to  GAT-MBSA, but not  GAT, by anti-theta-treated B10.S  spleen 
cells.  Thus,  the  development of  GAT-specific PFC  responses  in  spleen  cell 
cultures  are  dependent  upon  the  presence of thymus-derived  "helper"  cells 
expressing the relevant Ir gene. 
Macrophages from nonresponder mice can bind soluble GAT and stimulate 
nonadherent cells from responder mice to develop GAT-specific PFC responses. 
Precursors of antibody-producing cells from nonresponder mice can be stimu- 
lated to synthesize GAT-specific antibody under the appropriate experimental 
circumstances. The development of GAT-specific PFC responses is dependent 
upon thymus-derived cells. These pieces of information eliminate macrophages 
and B cells as the site of the defect in genetic nonresponder mice and establish 
that nonresponder mice lack GAT-specific thymus-derived "helper" cell func- 
tion. These experiments, however, do not rule out the possibility that in re- 
sponder animals the Ir gene products need to be expressed also in B  cells for 
physiological T  and B cell co-operation. 
A direct test of the issue would be to demonstrate that responder T  cells, in the 
presence  of  GAT,  can  stimulate  development of  GAT-specific PFC  responses  by 
nonresponder  B cells. This question has been investigated in vivo by one of us (B. 
Benacerraf) in collaboration  with Doctors Katz, Hamaoka, Doff, and Maurer (18) 
2 Rosenthal, A. S., and E. M. Shevach.  The function of macrophages  in antigen recognition 
by guinea pig T lymphocytes. I. Requirement for histocompatible  macrophages and lympho- 
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in another genetically  controlled response. The experimental  system  utilized  an im- 
mune response gene controlling antibody responses to the random terpolymer  of L- 
glutamic  acid-L-lysine-L-tyrosine (GLT)  and  its  hapten-conjugates  to  which  A/J 
mice  (H-2 °)  are  nonresponders  and BALB/c (tt-2 d)  and  (BALB/c)< A)F1 (CAF1) 
mice are responders. These studies demonstrated  that GLT primed T cells from CAF1 
mice can provide  helper function  for DNP-specific  responder  BALB/c B cells, but 
not for  nonresponder  A/J B  cells, in  the  development  of secondary  anti-DNP re- 
sponses to the DNP conjugate  of GLT. Preliminary  experiments  using the immune 
response to  GAT in vitro support  these  observations,  and will be the subject  of a 
separate  communication. These data might, at first glance, be interpreted  to indicate 
the need for both T  and B cells to express the relevant,  specific Ir gene. However, 
these  results  must be  interpreted  in light  of other observations  demonstrating  the 
importance  of the H-2  complex in  T  and  B  cell interactions  (19). It has,  indeed, 
been established  that T  and B cells are required  to share  a common 1t-2  allele for 
efficient physiological co-operation. If the Ir gene product in T cells is concerned with 
antigen presentation  to B cells, and if effective T and B cell interactions  involve the 
histocompatibility  molecules of the 11-2 complex, then the data discussed above simply 
indicate  that an Ir gene product expressed in F1 T  cells dictates  the 11-2  allele re- 
quired for effective co-operation and that the Ir gene product and the histocompafi- 
bility molecules coded for on the same 1t-2  allele are expressed in close relationships 
on the cell surface of thymus-derived  cells. This interpretation  is compatible with the 
report that in vitro blast  transformation  of sensitized guinea pig T cells by antigens 
under  Ir gene control  are  inhibited  by alloantisera  specific for  histocompatibility 
antigens  (20, 21). 
The  in  vitro  system  described  in  these  papers  can  be  used  effectively to 
resolve these  issues  and more specifically to study the effects of alloantisera 
directed against products coded for in the Ir region on immune responses under 
the control of histocompatibility-linked Ir genes. 
SUMMARY 
The cellular requirements for the development of primary IgG GAT-specific 
PFC responses in cultures of spleen cells from responder, C57B1/6, mice stimu- 
lated  with  GAT and  GAT-MBSA  and in  cultures  of spleen  cells  from non- 
responder, SJL and B 10.S, mice stimulated with GAT-MB  SA were investigated. 
Macrophages were required  for development of responses to GAT and GAT- 
MBSA in  cultures  of spleen  cells  from responder mice and  for responses  to 
GAT-MBSA in cultures of spleen cells from nonresponder mice. Macrophages 
from nonresponder mice supported the development of responses to GAT by 
nonadherent responder spleen cells, indicating that the failure of nonresponder 
mice  to  respond  to  GAT is  not  due  to  a  macrophage defect.  Furthermore, 
responder macrophages supported the responses of nonadherent, nonresponder 
spleen ceils to SRBC and GAT-MBSA, but not to GAT. This indicates that the 
capacity to respond to GAT is a function of the nonadherent population which is 
composed  of  thymus-derived  (T)  helper  cells  and  precursors  of  antibody- 7. A, KAPP, C. W. PIERCE, AND  B. BENACERRAP  1131 
producing cells. Treatment of spleen" cells  with anti-theta serum and comple- 
ment  before  culture  initiation abolished  PFC  responses  to  GAT and  GAT- 
MBSA thus establishing thexequirement for T  cells in the development of PFC 
responses to these antigens. 
Since precursors of antibody-producing cells in nonresponder mice are capable 
of synthesizing antibody specific  for GAT after stimulation with GAT-MBSA 
and  since  the  response  to  GAT is  thymus-dependent,  it  appears  that  non- 
responder mice lack GAT-specific helper T  cell function. 
We would like to thank Dr. P~ul Maurer for his generous gift of MBSA. We are grateful to 
Dr. Emile Unanue for his advice on the preparation of antigen-labeled macrophages. 
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